Rail Vision Announces $20 Million Standby Equity Purchase Agreement
Securing this strategic financial partnership will support Rail Vision’s expected market expansion, growth initiatives and financial requirements Ra’anana, Israel, Oct. […]
BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea
BURLINGTON, Mass. and JERUSALEM, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the […]
ProKidney to Participate in the UBS Virtual Organ Restoration Day
WINSTON-SALEM, N.C., Oct. 09, 2024 (GLOBE NEWSWIRE) — ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a late clinical-stage biotech company focused on the […]
Springbig Launches Innovative MP5 Messaging Feature with Remarkable Beta Test Results
BOCA RATON, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) — Springbig, the leading provider of loyalty and marketing solutions for the […]
Unicycive Therapeutics Successfully Completes UNI-494 Phase 1 Study in Healthy Volunteers
LOS ALTOS, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for […]
C4 Therapeutics Announces Presentations and Participation in 7th Annual Targeted Protein Degradation & Induced Proximity Summit
WATERTOWN, Mass., Oct. 09, 2024 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to […]
Nurix Therapeutics Announces Presentations at ACR Convergence 2024, the Annual Meeting of the American College of Rheumatology
SAN FRANCISCO, Oct. 09, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted […]
Kymera Therapeutics Announces FDA Clearance of Investigational New Drug Application for KT-621, a First-in-Class, Oral STAT6 Degrader
KT-621 has demonstrated dupilumab-like activity and was well tolerated ina wide variety of preclinical models of TH2 diseases KT-621 is […]
SemiCab Wins Major New Contract with $10 Billion Indian Consumer Packaged Goods Company for New Pilot in India
Multinational Consumer Goods Company Enters into aCommercially Scalable Pilot with SemiCab Serving the Indian Market Fort Lauderdale, FL, Oct. 09, […]
Entrada Therapeutics Presents New Data Supporting its Expanding Duchenne Franchise at the 29th Annual Congress of the World Muscle Society
– Additional positive data from the Company’s completed Phase 1 clinical trial evaluating ENTR-601-44 reinforces its safety profile and supports […]
